1. Home
  2. |Insights
  3. |COVID-19 Investigations Webinar – Current Congressional, Federal Agency, and State AG Oversight & Investigations Priorities

COVID-19 Investigations Webinar – Current Congressional, Federal Agency, and State AG Oversight & Investigations Priorities

Webinar | 07.15.20, 8:00 AM EDT - 9:00 AM EDT

Register

Join Crowell & Moring’s enforcement and investigations partners for a comprehensive overview of Congressional, Federal and State attorneys general COVID-19 enforcement actions. Learn about the prosecutions, Congressional document requests, formal investigations, and State actions underway. What industries, organizations, and companies have been targeted to date? How does the current enforcement focus impact future investigations? 


Our partners will provide an overview of matters that are currently of particular focus and offer their insights on what industry can expect in the coming months leading up to the 2020 elections. The panel will focus on oversight and investigations before:

  • Congress
  • Food and Drug Administration
  • Department of Health and Human Services
  • Department of Justice
  • State Attorneys General

The panel will include members of our Government Affairs, Health Care, White Collar, and State Attorneys General practice groups. The panelists include:

  • Jim Flood, a former federal prosecutor and counsel to Senator Charles E. Schumer (D-NY)
  • John Fuson, a former associate chief counsel at the Food and Drug Administration
  • Natalie O. Ludaway, former Chief Deputy of the Office of Attorney General (OAG) for the District of Columbia
  • Rebecca Monck Ricigliano, a former Assistant United States Attorney in the Southern District of New York and First Assistant Attorney General for New Jersey

For more information, please visit these areas: Government Affairs, White Collar and Regulatory Enforcement

Contact

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights